Titus B. Ball
CIK 1675628 · Principal Accounting Officer · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.47M
Companies
3
Total Filings
16
Lifetime Open-Market Net
-$137.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ONC | Principal Accounting Officer | 70,629 | $264.48 | $18.68M | -$111.4K | 3 | 2026-06-10 |
| BeOne Medicines Ltd. (BGNE) Delisted | Principal Accounting Officer | 0 | $184.71 | $0 | -$26.0K | 2 | 2024-09-05 |
| CSL | Chief Accounting Officer | 5,196 | $343.77 | $1.79M | $0 | 11 | 2021-02-17 |
Recent Filings · Page 2 of 2
16 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-06 | CSL | Grant (A) | +605 | $0 | EDGAR |
| 2019-01-03 | CSL | Mixed | −22 | -$30.6K | EDGAR |
| 2018-02-07 | CSL | Grant (A) | +515 | $0 | EDGAR |
| 2018-01-03 | CSL | Mixed | +20 | -$25.9K | EDGAR |
| 2017-02-09 | CSL | Grant (A) | +415 | $0 | EDGAR |
| 2017-01-04 | CSL | Mixed | +144 | -$47.6K | EDGAR |
Showing 11–16 of 16
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.